The formation of medical technology companies has proceeded at a steady pace over the past few years. These largely device-intensive companies are pursuing a range of clinical applications that is progressively more diverse, encompassing materials science, application of various hybrid technologies and, ultimately, often dissolving boundaries between devices, diagnostics, biotech, pharma and other traditional product [...]
bookmark to
